Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ettore Dolcetti

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Genes|May 28, 2022
Interleukin 6 SNP <i>rs1818879</i> Regulates Radiological and Inflammatory Activity in Multiple SclerosisAntonio Bruno, Ettore Dolcetti, Federica Azzolini, et al.
International Journal of Molecular Sciences|August 29, 2024
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple SclerosisEttore Dolcetti, Fabio Buttari, Antonio Bruno, et al.
Genes|February 25, 2022
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple SclerosisEttore Dolcetti, Antonio Bruno, Federica Azzolini, et al.
Journal of Neuroinflammation|May 14, 2024
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosisLivia Guadalupi, Valentina Vanni, Sara Balletta, et al.
International Journal of Molecular Sciences|May 25, 2024
Interaction between miR-142-3p and <i>BDNF</i> Val/Met Polymorphism Regulates Multiple Sclerosis SeverityEttore Dolcetti, Alessandra Musella, Sara Balletta, et al.
Current Neuropharmacology|April 6, 2023
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple SclerosisFrancesca De Vito, Sara Balletta, Silvia Caioli, et al.
Frontiers in Molecular Neuroscience|August 22, 2024
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosisLuana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Frontiers in Immunology|June 24, 2024
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosisKrizia Sanna, Antonio Bruno, Sara Balletta, et al.
Neurobiology of Disease|July 14, 2022
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosisLuana Gilio, Diego Fresegna, Antonietta Gentile, et al.
Cells|February 10, 2021
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple SclerosisGeorgia Mandolesi, Francesca Romana Rizzo, Sara Balletta, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Genes|May 28, 2022
Interleukin 6 SNP <i>rs1818879</i> Regulates Radiological and Inflammatory Activity in Multiple SclerosisAntonio Bruno, Ettore Dolcetti, Federica Azzolini, et al.
International Journal of Molecular Sciences|August 29, 2024
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple SclerosisEttore Dolcetti, Fabio Buttari, Antonio Bruno, et al.
Genes|February 25, 2022
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple SclerosisEttore Dolcetti, Antonio Bruno, Federica Azzolini, et al.
Journal of Neuroinflammation|May 14, 2024
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosisLivia Guadalupi, Valentina Vanni, Sara Balletta, et al.
International Journal of Molecular Sciences|May 25, 2024
Interaction between miR-142-3p and <i>BDNF</i> Val/Met Polymorphism Regulates Multiple Sclerosis SeverityEttore Dolcetti, Alessandra Musella, Sara Balletta, et al.
Current Neuropharmacology|April 6, 2023
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple SclerosisFrancesca De Vito, Sara Balletta, Silvia Caioli, et al.
Frontiers in Molecular Neuroscience|August 22, 2024
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosisLuana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Frontiers in Immunology|June 24, 2024
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosisKrizia Sanna, Antonio Bruno, Sara Balletta, et al.
Neurobiology of Disease|July 14, 2022
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosisLuana Gilio, Diego Fresegna, Antonietta Gentile, et al.
Cells|February 10, 2021
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple SclerosisGeorgia Mandolesi, Francesca Romana Rizzo, Sara Balletta, et al.
Pageof 5